|
Sign In to gain access to subscriptions and/or personal tools.
|
Lipopolysaccharide enhances interferon- -induced nitric oxide (NO) production in murine vascular endothelial cells via augmentation of interferon regulatory factor-1 activation
Naoki Koide
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan, koide{at}aichi-med-u.ac.jp
Mya Mya Mu
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Ferdaus Hassan
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Shamima Islam
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Gantsetseg Tumurkhuu
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Jargalsaikhan Dagvadorj
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Yoshikazu Naiki
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Isamu Mori
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Tomoaki Yoshida
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Takashi Yokochi
Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
Lipopolysaccharide (LPS) enhances the production of nitric oxide (NO) in interferon (IFN)- stimulated vascular endothelial cells. We studied the mechanism by which LPS enhances IFN- -induced NO production by using the murine vascular endothelial cell line, END-D. LPS enhanced IFN- induced NO production via augmented expression of inducible type NO synthase (iNOS) mRNA. LPS significantly augmented the activation of interferon regulatory factor (IRF)-1 in IFN- -stimulated END-D cells, although it did not affect the activation of either MyD88-dependent nuclear factor (NF)- B or MyD88-independent IRF-3. SB203580, an inhibitor of p38 mitogen-activated protein kinase (MAPK), prevented the nuclear translocation of IRF-1 in LPS and IFN- -stimulated END-D cells, and inhibited the iNOS expression and NO production in those cells. Therefore, it is proposed that LPS enhanced NO production in IFN- -stimulated END-D cells via augmenting p38 MAPKmediated IRF-1 activation.
Key Words: LPS interferon- nitric oxide vascular endothelial cell IRF-1
Journal of Endotoxin Research, Vol. 13, No. 3,
167-175 (2007)
DOI: 10.1177/0968051907080894

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|